These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 32992133)
1. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020). Xiao J; Gao M; Sun Z; Diao Q; Wang P; Gao F Eur J Med Chem; 2020 Dec; 208():112830. PubMed ID: 32992133 [TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Application of Podophyllotoxin Derivatives to Fight Against Multidrug-Resistant Cancer Cells. Guo Q; Jiang E Curr Top Med Chem; 2021; 21(19):1712-1724. PubMed ID: 33441065 [TBL] [Abstract][Full Text] [Related]
3. Podophyllotoxins: current status and recent developments. Damayanthi Y; Lown JW Curr Med Chem; 1998 Jun; 5(3):205-52. PubMed ID: 9562603 [TBL] [Abstract][Full Text] [Related]
4. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities. Yang M; Liu H; Zhang Y; Wang X; Xu Z Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464 [TBL] [Abstract][Full Text] [Related]
5. Toward synthesis of third-generation spin-labeled podophyllotoxin derivatives using isocyanide multicomponent reactions. Kou L; Wang MJ; Wang LT; Zhao XB; Nan X; Yang L; Liu YQ; Morris-Natschke SL; Lee KH Eur J Med Chem; 2014 Mar; 75():282-8. PubMed ID: 24553146 [TBL] [Abstract][Full Text] [Related]
6. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs. Zhang X; Rakesh KP; Shantharam CS; Manukumar HM; Asiri AM; Marwani HM; Qin HL Bioorg Med Chem; 2018 Jan; 26(2):340-355. PubMed ID: 29269253 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010). Lv M; Xu H Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026 [TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. Part 227: Studies on novel 4'-O-demethyl-epipodophyllotoxins as antitumor agents targeting topoisomerase II. Xiao Z; Bastow KF; Vance JR; Lee KH Bioorg Med Chem; 2004 Jun; 12(12):3339-44. PubMed ID: 15158802 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and potent cytotoxic activity of novel podophyllotoxin derivatives. Li WQ; Wang XL; Qian K; Liu YQ; Wang CY; Yang L; Tian J; Morris-Natschke SL; Zhou XW; Lee KH Bioorg Med Chem; 2013 Apr; 21(8):2363-2369. PubMed ID: 23490151 [TBL] [Abstract][Full Text] [Related]
10. Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series. Etievant C; Schambel P; Guminski Y; Barret JM; Imbert T; Hill BT Anticancer Drug Des; 1998 Jun; 13(4):317-36. PubMed ID: 9627671 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171 [TBL] [Abstract][Full Text] [Related]
12. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007. Xu H; Lv M; Tian X Curr Med Chem; 2009; 16(3):327-49. PubMed ID: 19149581 [TBL] [Abstract][Full Text] [Related]
13. Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents. Liu YQ; Tian J; Qian K; Zhao XB; Morris-Natschke SL; Yang L; Nan X; Tian X; Lee KH Med Res Rev; 2015 Jan; 35(1):1-62. PubMed ID: 24827545 [TBL] [Abstract][Full Text] [Related]
14. Design and Synthesis of Novel Podophyllotoxins Hybrids and the Effects of Different Functional Groups on Cytotoxicity. Yang Z; Zhou Z; Luo X; Luo X; Luo H; Luo L; Yang W Molecules; 2021 Dec; 27(1):. PubMed ID: 35011453 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA. Yadav AA; Wu X; Patel D; Yalowich JC; Hasinoff BB Bioorg Med Chem; 2014 Nov; 22(21):5935-49. PubMed ID: 25282653 [TBL] [Abstract][Full Text] [Related]
16. Podophyllotoxin derivatives: current synthetic approaches for new anticancer agents. You Y Curr Pharm Des; 2005; 11(13):1695-717. PubMed ID: 15892669 [TBL] [Abstract][Full Text] [Related]